This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Automaker groups from US, Europe, Korea, Japan ask Avanci to resolve 'pressing concerns' over patent licensing rates

( July 11, 2024, 23:55 GMT | Official Statement) -- MLex Summary: Automaker associations from the US, Europe, France, Germany, Korea and Japan have written to Avanci founder and Chief Executive Kasim Alfalahi asking to resolve "pressing concerns" about the lack of transparency of its patent pool's licensing program and commercial terms. Avanci doesn't provide any indication of how Avanci has confirmed that the included patents are actually standard essential nor does Avanci provide any pertinent information on how the included SEPs are licensed on fair, reasonable and non-discriminatory, or Frand, terms, they said in a letter. "Avanci is willing to license only automakers of 5G connected vehicles but not, for example, manufacturers of the components actually implementing the 5G technology. What is the reason for refusing to license those immediate implementers of 5G technology on FRAND terms?" the letter asked.Statement follows. See attached document...

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Documents

Related Sections